RSC Medicinal Chemistry

SJR Rank #7,475H-index: 87SJR: 0.756Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Royal Society of Chemistry

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Organic ChemistryQ1
  • BiochemistryQ2
  • Drug DiscoveryQ2
  • Molecular MedicineQ2
  • Pharmaceutical ScienceQ2
  • PharmacologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Synthesis and biological activityClick Chemistry and ApplicationsComputational Drug Discovery MethodsProtein Degradation and InhibitorsCancer therapeutics and mechanismsSynthesis and Biological EvaluationDiverse Scientific and Economic StudiesChemical Synthesis and AnalysisPeptidase Inhibition and AnalysisCholinesterase and Neurodegenerative Diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025085170255340

Detailed Information

ISSN

2632-8682

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.34

References per Document

65.10

Coverage

2020-2026

Scope

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Examples of areas within the journal's scope are: - Design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities. To be suitable for publication these must ex-hibit significant potential as new pharmacological agents, tools, probes or potential drugs. - Modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity re-lationships, an improvement of their properties or provide other infor-mation of significant value, for example, the identification of a new target or mode of action for a known agent. Routine modifications with minimal or no improvement are not suitable for RSC Medicinal Chemistry. - Novel methodologies and technologies in the broader chemical and bio-logical sciences (for example, enabling synthetic chemistry, chemical bi-ology, -omics sciences, nanoscience) with application to drug discovery, target identification or elucidation of the mechanism of action. Biological studies should present sufficient innovation with respect to the chemistry.

Metrics from SCImago Journal Rank 2025. View on SCImago